Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)

• Status: Completed
• Trial end date: 2005-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare intensive and standard training for human insulin inhalation powder in patients with type 2 diabetes.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Collaborator: Alkermes, Inc.

Criteria

Inclusion Criteria:

• Type 2 diabetes for at least 12 months

• Age 18 or older.

• Taking at least 1 oral antihyperglycemic medication.

• Have an HbA1C between 7.5 and 12.

• Be a nonsmoker

Exclusion Criteria:

• Body Mass Index (BMI) greater than 40.

• Have frequent episodes of severe hypoglycemia.

• Have advanced autonomic neuropathy.

• Have history of asthma.

• Have chronic obstructive pulmonary disease (COPD).